Trial Profile
Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic: An Observational Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Convalescent anti-SARS-CoV-2 plasma (Primary) ; Hydroxychloroquine (Primary) ; Interferon beta-1a (Primary) ; Ivermectin (Primary) ; Oplunofusp (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 10 Jul 2020 New trial record